Finance

Beta
Lists
REVBW:NASDAQ
Revelation Biosciences
$0.011
+11.88%
(+0.0012) 1D
$0.011
0.00% (0.00)
After hours
Closed: Jun 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REVBW...
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
4.06M
Avg. vol.
110.01K
Volume
1.40K
52-wk high
$0.04
52-wk low
$0.00
Beta
3.37
No. of employees
8
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
4.06M
Avg. vol.
110.01K
Volume
1.40K
52-wk high
$0.04
52-wk low
$0.00
Beta
3.37
No. of employees
8
News stories
From sources across the web
About Revelation Biosciences
CEO-
Employees8
Founded2019
Headquarters-
SectorBiotechnology
Websiterevbiosciences.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.32M
922.86K
964.19K
1.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14M
1.02M
1.61M
1.72M
Operating expense
2.46M
1.94M
2.57M
3.09M
Total operating expenses
2.46M
1.94M
2.57M
3.09M
Operating income
-2.46M
-1.94M
-2.57M
-3.09M
Other non operating income
16.85K
35.84K
60.58K
83.45K
EBT including unusual items
-2.44M
-1.91M
-2.51M
-3.01M
EBT excluding unusual items
-2.44M
-1.91M
-2.51M
-3.01M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.44M
-1.91M
-2.51M
-3.01M
Net profit margin
-
-
-
-
Earnings per share
-28.04
-7.08
-1.65
-2.71
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.45M
-1.94M
-2.57M
-3.09M
Gain or loss from assets sale
-
4.49K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer